The crew of a Southwest Airlines Co. (NYSE:LUV) flight declared an emergency en route from Orlando, Florida, to Milwaukee, because of an electrical smell in the back of the plane. Southwest Airlines Co. (NYSE:LUV) belongs to Services sector. Its net profit margin is 6.00% and weekly performance is 7.14%. On last trading day company shares ended up $30.75. Southwest Airlines Co. (NYSE:LUV) distance from 50-day simple moving average (SMA50) is 10.57%.

Luoxis Diagnostics, Inc., a subsidiary of Ampio Pharmaceuticals, Inc. (AMEX: AMPE), announced an upcoming presentation at the 73rd Annual Meeting of the American Academy of Surgical Trauma (AAST) and Clinical Congress of Acute Care Surgery in Philadelphia, Pennsylvania that will be held September 10-13, 2014. The presentation will report results from a recently completed five-year prospective clinical trial conducted using Luoxis’ proprietary RedoxSYS oxidation-reduction potential (ORP) diagnostic platform to assess prognosis and outcomes in patients with traumatic brain injury. Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) shares moved up 5.60% in last trading session and ended the day at $7.54. AMPE return on assets is -63.10%. Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) quarterly performance is 0.00%.

Active Power (NASDAQ: ACPW) reported results for the second quarter ended June 30, 2014. Highlights — UPS revenue increased $3.3 million from the second quarter of 2013 to $6.2 million, but decreased $477,000 from the previous quarter.On 19 August, Active Power Inc. (NASDAQ:ACPW) shares moved up 0.88% and was closed at $2.30. ACPW EPS growth in last 5 year was 17.40%. Active Power Inc. (NASDAQ:ACPW) year to date (YTD) performance is -31.75%.

EnerNOC (NASDAQ:ENOC) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research note issued to investors on Wednesday. EnerNOC, Inc. (NASDAQ:ENOC) ended the last trading day at $19.68. Company weekly volatility is calculated as 2.54%and price to cash ratio as 5.51. EnerNOC, Inc. (NASDAQ:ENOC) showed a weekly performance of -0.56%.

Georgia Erbez, CFO of Raptor Pharmaceutical Corp. (RPTP) said the company has initiated an 18-month Huntington disease trial. She spoke at the Canaccord Genuity 34th Annual Growth Conference at the Intercontinental Hotel in Boston, Massachusetts. Raptor Pharmaceuticals Corp. (NASDAQ:RPTP) shares moved up 4.67% in last trading session and ended the day on $11.44. RPTP Gross Margin is 89.70% and its return on assets is -66.70%. Raptor Pharmaceuticals Corp. (NASDAQ:RPTP) quarterly performance is 32.10%.